Multimodality cardiovascular imaging in the midst of the COVID-19 pandemic: ramping up safely to a new normal

WA Zoghbi, MF DiCarli, R Blankstein, AD Choi… - Cardiovascular …, 2020 - jacc.org
The coronavirus disease 2019 (COVID-19) pandemic created an unprecedented disruption
to routine patient care (1). Health care professionals scrambled within weeks to attend to the …

[HTML][HTML] Cardiac manifestations of coronavirus (COVID-19)

I Basu-Ray, A Adeboye, MP Soos - StatPearls [Internet], 2023 - ncbi.nlm.nih.gov
Cardiac Manifestations Of Coronavirus (COVID-19) - StatPearls - NCBI Bookshelf US flag
An official website of the United States government Here's how you know NIH NLM Logo …

Multimodality imaging for cardiac evaluation in patients with COVID-19

E Goerlich, AS Minhas, M Mukherjee… - Current Cardiology …, 2021 - Springer
Purpose of Review A growing number of cardiovascular manifestations resulting from the
novel SARS-CoV-2 coronavirus (COVID-19) have been described since the beginning of …

Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe

MC Williams, L Shaw, CB Hirschfeld… - Open …, 2021 - openheart.bmj.com
Objectives We aimed to explore the impact of the COVID-19 pandemic on cardiac diagnostic
testing and practice and to assess its impact in different regions in Europe. Methods The …

American Society of Echocardiography COVID-19 Statement Update: Lessons Learned and Preparation for Future Pandemics

JN Kirkpatrick, M Swaminathan, A Adedipe… - Journal of the American …, 2023 - Elsevier
The COVID-19 pandemic has evolved since the publication of the initial American Society of
Echocardiography (ASE) statements providing guidance to echocardiography laboratories …

Exercise testing in COVID‐19 era: Clinical profile, results and feasibility wearing a facemask

C Barbeito‐Caamaño… - European journal of …, 2021 - Wiley Online Library
Background No data are available about whether Coronavirus disease 2019 (COVID‐19)
pandemic have led to changes in clinical profiles or results of exercise testing once the …

COVID‐19 pathophysiology and ultrasound imaging: A multiorgan review

GNW Ito, VAC Rodrigues, J Hümmelgen… - Journal of Clinical …, 2022 - Wiley Online Library
COVID‐19 is a dynamic disease and may affect different tissues and organs as it
progresses. Therefore, the impact generated by the disease in all its stages and organs …

Легочная гипертензия как фактор оценки риска неблагоприятного исхода у пациентов с COVID-19

ЕЗ Голухова, ИВ Сливнева, ММ Рыбка… - Российский …, 2020 - cyberleninka.ru
Цель. Выяснение прогностической роли расчетного систолического давления в
легочной артерии у пациентов с новой коронавирусной инфекцией (COVID-19) …

[HTML][HTML] Pulmonary hypertension as a risk assessment factor for unfavorable outcome in patients with COVID-19

EZ Golukhova, IV Slivneva, MM Rybka… - Russian Journal of …, 2020 - russjcardiol.elpub.ru
Aim. To determine the predictive role of estimated pulmonary artery systolic pressure
(ePASP) in COVID-19 patients. Material and methods. A retrospective study of inpatients …

The Role of Intracardiac Echocardiography in Percutaneous Tricuspid Intervention: A New ICE Age.

D Hagemeyer, FM Ali, G Ong, NP Fam - Interventional Cardiology …, 2022 - europepmc.org
The prevalence of severe tricuspid regurgitation in older patients is high, and the clinical
relevance is perceived more and more in recent years. Many of these patients are not …